
CRMD
CorMedix Inc.
$14.83
+$0.48(+3.34%)
34
Overall
30
Value
30
Tech
42
Quality
Market Cap
$1.04B
Volume
2.67M
52W Range
$5.31 - $17.43
Target Price
$19.33
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $210.1K | $224.1K | $329.3K | $429.8K | $283.3K | $239.2K | $190.9K | $65.4K | -- | $43.5M | ||
Total Revenue | $210.1K | $224.1K | $329.3K | $429.8K | $283.3K | $239.2K | $190.9K | $65.4K | -- | $43.5M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $318.7K | $-366.7K | $-115.0K | $-396.8K | $373.2K | $204.8K | $148.9K | $3.7K | -- | $3.2M | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $-108.6K | $-142.6K | $214.4K | $33.0K | $-90.0K | $34.4K | $42.0K | $61.7K | -- | $40.3M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $-16.5M | $-24.6M | $-33.1M | $-26.9M | $20.9M | $27.3M | $29.5M | $30.7M | $49.0M | $62.6M | ||
Research & Development | $6.3M | $15.7M | $24.5M | $18.8M | $11.1M | $13.4M | $13.1M | $10.7M | $13.2M | $3.9M | ||
Research Expense | $6.3M | $15.7M | $24.5M | $18.8M | $11.1M | $13.4M | $13.1M | $10.7M | $13.2M | $3.9M | ||
Selling, General & Administrative | $10.3M | $8.9M | $8.7M | $8.1M | $9.9M | $13.9M | $16.3M | $20.0M | $35.8M | $58.7M | ||
Selling & Marketing Expenses | -- | -- | -- | $8.1M | $9.9M | -- | -- | $3.7K | $18.1M | $28.7M | ||
General & Administrative Expenses | $10.3M | $8.9M | $8.7M | $8.1M | $-6.0K | $13.9M | $16.3M | $20.0M | $17.7M | $30.0M | ||
Salaries & Wages | $-640.0K | $-2.9M | $-1.4M | $-1.0M | $-2.2M | -- | -- | -- | -- | -- | ||
Amortization | -- | -- | -- | -- | $-313.1K | -- | -- | -- | -- | $155.8K | ||
Other Operating Expenses | $1.6M | $117.3K | -- | -- | $-2.0K | $66.0K | $209.0K | $208.0K | $49.0M | $62.6M | ||
OPERATING INCOME | ||||||||||||
Operating income | $-17.7M | $-24.8M | $-32.9M | $-26.9M | $-21.0M | $-27.2M | $-29.4M | $-30.6M | $-49.0M | $-22.4M | ||
EBITDA | $-17.7M | $-24.6M | $-33.0M | $-26.8M | $-20.3M | $-27.0M | $-29.4M | $-30.2M | $-44.6M | $-20.3M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $4.0K | $1.3K | $5.6K | $1.9K | $787.5K | $33.2K | $15.9K | $26.5K | $34.3K | $-1.4M | ||
Interest Income Operating | -- | -- | -- | -- | $26.7M | -- | -- | -- | -- | -- | ||
Intinc | $60.4K | $126.8K | $110.7K | $36.6K | $322.7K | $116.1K | $14.4K | $326.0K | $2.7M | $2.6M | ||
Net Non-Operating Interest Income/Expense | $56.4K | $125.5K | $105.1K | $34.7K | $-464.8K | $82.8K | $-1.5K | $299.5K | $2.7M | $2.6M | ||
Gain on Sale of Securities | $-24.2K | $11.0K | $13.1K | -- | $1.8K | -- | -- | -- | -- | -- | ||
Other Income/Expense | $24.2K | $-11.0K | $164.0K | -- | $-1.8K | $204.8K | -- | $37.1K | $-29.0K | $-520.0K | ||
Other Special Charges | -- | -- | $-177.1K | -- | -- | $1.4M | -- | -- | -- | $520.0K | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | -- | -- | -- | -- | -- | -- | $3.7K | -- | -- | ||
Special Income Charges | -- | -- | -- | -- | $-26.7M | -- | -- | $-3.7K | -- | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-17.7M | $-24.6M | $-33.0M | $-26.8M | $-20.7M | $-27.2M | $-29.4M | $-30.3M | $-44.8M | $-20.7M | ||
Pre-Tax Income | $-17.7M | $-24.6M | $-33.0M | $-26.8M | $-21.5M | $-27.2M | $-29.5M | $-30.3M | $-46.3M | $-19.3M | ||
INCOME TAX | ||||||||||||
Tax Provision | -- | -- | -- | -- | $-5.1M | $-5.2M | $-1.3M | $-585.6K | $1.5M | $-1.4M | ||
NET INCOME | ||||||||||||
Net Income | $-17.7M | $-24.6M | $-33.0M | $-26.8M | $-32.9M | $-22.0M | $-28.2M | $-29.7M | $-46.3M | $-17.9M | ||
Net Income (Continuing Operations) | $-17.7M | $-24.6M | $-33.0M | $-26.8M | $-32.9M | $-22.0M | $-28.2M | $-29.7M | $-46.3M | $-17.9M | ||
Net Income (Discontinued Operations) | $-17.7M | $-24.6M | $-33.0M | $-26.8M | $-32.9M | $-22.0M | $-28.2M | $-29.7M | $-46.3M | $-17.9M | ||
Net Income (Common Stockholders) | $-17.6M | $-24.6M | $-33.0M | $-26.8M | $-60.0M | $-22.0M | $-28.2M | $-29.7M | $-46.3M | $-17.9M | ||
Normalized Income | -- | -- | -- | -- | -- | -- | $-30.7M | -- | -- | $-20.7M | ||
TOTALS | ||||||||||||
Total Expenses | $-16.2M | $-25.0M | $-33.3M | $-27.3M | $21.3M | $27.5M | $29.6M | $30.7M | $49.0M | $65.8M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $6.3M | $7.6M | $11.0M | $17.8M | $24.2M | $28.6M | $37.7M | $40.3M | $50.9M | $58.9M | ||
Average Shares Outstanding (Diluted) | $6.1M | $7.4M | $11.0M | $3.6M | $24.2M | $28.6M | -- | $40.3M | $50.9M | $58.9M | ||
Shares Outstanding | $7.2M | $8.1M | $16.3M | $23.8M | $26.1M | $38.0M | $38.7M | $44.5M | $74.6M | $74.6M | ||
Basic EPS | -- | -- | -- | $-7.55 | -- | $-0.77 | $-0.75 | $-0.74 | $-0.91 | $-0.30 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-0.77 | $-0.75 | $-0.74 | $-0.91 | $-0.30 | ||
Diluted EPS | $-2.9 | $-3.25 | $-3 | $-1.5 | $-1.8 | $-0.77 | $-0.75 | $-0.74 | $-0.91 | $-0.30 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-1.8 | -- | -- | $-0.74 | $-0.91 | $-0.30 | ||
OTHER METRICS | ||||||||||||
Accrued Preferred Stock Dividends | $-33.1K | -- | -- | -- | $27.1M | -- | -- | -- | -- | -- | ||
Acquired In Process Rn D | -- | -- | -- | -- | $-26.7M | -- | -- | -- | -- | -- | ||
Allowances For Construction | -- | -- | -- | -- | -- | $204.8K | -- | -- | -- | -- | ||
Earnings from equity interest | -- | -- | -- | -- | $-369.5K | -- | -- | -- | -- | -- | ||
Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | $-369.5K | -- | -- | -- | -- | -- | ||
Excise Taxes | -- | -- | -- | -- | -- | $204.8K | -- | -- | -- | -- | ||
Loss And Loss Adjustment Expected Incurred | -- | -- | -- | -- | $-396.0K | -- | -- | -- | -- | -- | ||
Minority Interests | -- | -- | -- | -- | -- | $-22.0M | $-28.2M | -- | -- | -- | ||
Net Income Extraordinary | -- | -- | -- | -- | $-16.4M | $-22.0M | -- | -- | -- | -- | ||
Non Recurring Operation Expense | -- | -- | -- | -- | $-267.0K | -- | -- | -- | -- | -- | ||
Other Gand A | $10.3M | $8.9M | $8.7M | $8.1M | $-6.0K | $13.9M | $16.3M | $20.0M | $17.7M | $30.0M | ||
Otherunder Preferred Stock Dividend | $-33.1K | -- | -- | -- | $27.1M | -- | -- | -- | -- | -- | ||
Preferred Stock Dividends | $-33.1K | -- | -- | -- | $27.1M | -- | -- | -- | -- | -- | ||
Rent And Landing Fees | $10.3M | $8.9M | $8.7M | $8.1M | -- | -- | -- | -- | -- | -- | ||
Selling Expense | -- | -- | -- | $8.1M | $9.9M | -- | -- | $3.7K | -- | -- | ||
Restruct | -- | -- | -- | -- | -- | -- | -- | $3.7K | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | CRMD | $14.83 | +3.3% | 2.67M |
3 | ||||
4 | ||||
5 | ||||
6 |